Platinum (IV) cisplatin
Alternative Names: Cisplatin - University of Edinburgh; Laser-activated cisplatin; Pt(IV) cisplatinLatest Information Update: 14 Feb 2007
At a glance
- Originator Nonindustrial source
- Class
- Mechanism of Action DNA cross linking agents; DNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 06 Jul 1999 Preclinical development for Cancer in Scotland (unspecified route)